Istari Oncology

Istari Oncology is a biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma.

Istari Oncology is a company in biotechnology, health care, medical, oncology based in Research Triangle, East Coast, Southern US, founded in 2014.

Within the biotechnology, health care, medical, oncology space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Research Triangle, East Coast, Southern US.

It is recorded at the Series_Unknown stage.

Its team size is recorded as c_00011_00050 employees.

Public records show total funding of about $48.5M.

Website: www.istarioncology.com